Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Prototype CT tools for minimally invasive intracerebral hemorrhage evacuation

Official title: Feasibility of the Utilization of Siemens Prototypes in Minimally Invasive ICH Evacuation Treatment

Run by Icahn School of Medicine at Mount Sinai · NCT07455201 · Data updated 2026-11-12

This project will test two Siemens prototype CT tools—a perfusion feature and an automatic hemorrhage detector—to see if they help doctors planning and performing minimally invasive brain-bleed (intracerebral hemorrhage) evacuation in adults.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment15 (estimated)
SponsorIcahn School of Medicine at Mount Sinai
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedOctober 31, 2025
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedMay 6, 2026
Trial IDNCT07455201 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) who are scheduled to undergo minimally invasive hemorrhage evacuation at Mount Sinai West are eligible.

Probably not a fit

Patients under 18, or those not undergoing minimally invasive hemorrhage evacuation at Mount Sinai West, are not eligible and unlikely to benefit from these specific prototypes.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The project prospectively collects pre-procedural CT scans, intra-procedural DynaCT Sine Spin and DynaCT Multiphase scans taken immediately after evacuation, and immediate post-procedural CT scans to test two Siemens prototypes (a perfusion prototype and an automatic hemorrhage detection prototype). In addition, five retrospectively collected pre- and post-procedural datasets acquired during routine care will be included. Treating clinicians will provide structured feedback on feasibility, usefulness, and potential clinical value during minimally invasive ICH procedures at Mount Sinai West. The aim is to characterize operational performance and identify potential workflow and outcome benefits of these imaging features.

Why it matters

Potential benefit: If successful, these CT prototypes could help surgeons locate and confirm clot removal more quickly and accurately, potentially improving recovery and reducing complications.

How similar studies have gone: Imaging-guided approaches for ICH have shown promise, but the specific Siemens perfusion and automatic-bleed-detection prototypes tested here are relatively new and have limited published clinical data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient ≥ 18 years old
* Patient is planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital

Exclusion Criteria:

* Patient is \< 18 years old
* Patient is not planned to undergo minimally invasive hemorrhage evacuation at Mount Sinai West Hospital

Where it's running

  • Mount Sinai West
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.